ArticleJAMA network open2022

Analysis of Rituximab Use, Time Between Rituximab and SARS-CoV-2 Vaccination, and COVID-19 Hospitalization or Death in Patients With Multiple Sclerosis.

Jessica B Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.